1. Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism. (20th November 2007) Authors: Kersten, Sander Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. (23rd December 2007) Authors: Cresci, Sharon Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. (23rd December 2007) Authors: Cresci, Sharon Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. (24th March 2008) Authors: Cresci, Sharon Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. (24th March 2008) Authors: Cresci, Sharon Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Should We Use PPAR Agonists to Reduce Cardiovascular Risk?. (26th November 2007) Authors: Robinson, Jennifer G. Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Should We Use PPAR Agonists to Reduce Cardiovascular Risk?. (26th November 2007) Authors: Robinson, Jennifer G. Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Should We Use PPAR Agonists to Reduce Cardiovascular Risk?. (28th January 2008) Authors: Robinson, Jennifer G. Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The PPARα-PGC-1α Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium. (22nd November 2007) Authors: Duncan, Jennifer G.; Finck, Brian N. Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The PPARα-PGC-1α Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium. (4th November 2007) Authors: Duncan, Jennifer G.; Finck, Brian N. Other Names: Chinetti Giulia Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗